Comparative Effectiveness of Infliximab Versus Adalimumab in Patients with Biologic-Naïve Crohn’s Disease
Crossref DOI link: https://doi.org/10.1007/s10620-017-4874-6
Published Online: 2017-12-14
Published Print: 2018-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Benmassaoud, Amine
Al-Taweel, Talal
Sasson, Mark Solomon
Moza, Dasha
Strohl, Matthew
Kopylov, Uri
Paradis-Surprenant, Laurence
Almaimani, Mohanad
Bitton, Alain
Afif, Waqqas
Lakatos, Peter L.
Bessissow, Talat
License valid from 2017-12-14